<DOC>
	<DOCNO>NCT02054078</DOCNO>
	<brief_summary>Patients Malignant pleural effusion diagnosis advance cancer . Currently recognize reliable method control malignant pleural effusion pleural fix thoracic catheter drainage . The effective pleural fix agent pulvis talci , 30 % relapse rate . Thoracic drainage lead complication , chest infection , catheter migration blockage etc . The investigator need reliable method solve dyspnea symptom cause malignant pleural effusion , improve quality life . The purpose study determine efficacy Safety intrapleural Bevacizumab versus pulvis talci treatment malignant pleural effusion ( MPE ) patient .</brief_summary>
	<brief_title>Efficacy Safety Bevacizumab Versus Pulvis Talci Malignant Pleural Effusion</brief_title>
	<detailed_description>Backgroundï¼š Patients Malignant pleural effusion diagnosis advance cancer . Currently recognize reliable method control malignant pleural effusion pleural fix thoracic catheter drainage . The effective pleural fix agent pulvis talci , 30 % relapse rate . Thoracic drainage lead complication , chest infection , catheter migration blockage etc . The investigator need reliable method solve dyspnea symptom cause malignant pleural effusion , improve quality life . The purpose study determine efficacy Safety intrapleural Bevacizumab versus pulvis talci treatment malignant pleural effusion ( MPE ) patient . Methods : A unblended , randomize study compare inhibition two treatment method malignant pleural effusion . Consecutive 183 patient randomly assign two group , A group Bevacizumab200mg intrapleural administration ; B group inject pulvis talci close thoracic drainage .</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>1 . Diagnose malignant pleural effusion : Diagnose malignant pleural neoplasm histopathology Recurrent pleural effusion , Histologically cytologically confirm diagnosis cancer 2 . Written inform consent 1 . &lt; 18years age 2 . Expected survival &lt; 3 month 3 . Chest infection , chylothorax , pleurodesis ipsilateral lung surgery 4 . Planned chemotherapy 5 . Pregnancy breastfeeding ( woman childbearing potential ) 6 . Not sign inform consent noncompliance treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>